19:58:55 Europe / Stockholm
Svenska | English

ChemoMetec

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-10 Årsstämma 2025
2024-09-11 Bokslutskommuniké 2024
2024-02-05 Kvartalsrapport 2024-Q2
2023-10-13 Ordinarie utdelning CHEMM 6.00 DKK
2023-10-12 Årsstämma 2024
2023-09-14 Bokslutskommuniké 2023
2023-05-09 15-10 2023-Q3
2023-02-09 Kvartalsrapport 2023-Q2
2022-10-14 Ordinarie utdelning CHEMM 0.00 DKK
2022-10-13 Årsstämma 2023
2022-09-15 Bokslutskommuniké 2022
2022-02-08 Kvartalsrapport 2022-Q2
2021-10-15 Ordinarie utdelning CHEMM 4.00 DKK
2021-10-14 Årsstämma 2022
2021-09-16 Bokslutskommuniké 2021
2021-02-05 Kvartalsrapport 2021-Q2
2020-10-09 Ordinarie utdelning CHEMM 1.50 DKK
2020-10-08 Årsstämma 2021
2020-09-17 Bokslutskommuniké 2020
2020-02-07 Kvartalsrapport 2020-Q2
2020-01-14 Bonusutdelning CHEMM 13
2020-01-13 Extra Bolagsstämma 2020
2019-10-11 Ordinarie utdelning CHEMM 7.50 DKK
2019-10-10 Årsstämma 2020
2019-09-17 Bokslutskommuniké 2019
2019-02-08 Kvartalsrapport 2019-Q2
2018-10-12 Ordinarie utdelning CHEMM 0.00 DKK
2018-10-11 Årsstämma 2019
2018-09-18 Bokslutskommuniké 2018
2018-02-09 Kvartalsrapport 2018-Q2
2017-11-15 Årsstämma 2018
2017-10-13 Ordinarie utdelning CHEMM 0.00 DKK
2017-10-12 Årsstämma 2018
2017-09-19 Bokslutskommuniké 2017
2017-02-10 Kvartalsrapport 2017-Q2
2016-10-14 Ordinarie utdelning CHEMM 0.00 DKK
2016-10-13 Årsstämma 2017
2016-09-20 Bokslutskommuniké 2016
2016-02-26 Kvartalsrapport 2016-Q2
2015-10-09 Ordinarie utdelning CHEMM 0.00 DKK
2015-10-08 Årsstämma 2016
2015-05-15 Kvartalsrapport 2015-Q3
2014-10-10 Ordinarie utdelning CHEMM 0.00 DKK
2014-10-09 Årsstämma 2015
2014-05-15 Kvartalsrapport 2014-Q3
2013-11-15 Kvartalsrapport 2014-Q1
2013-10-11 Ordinarie utdelning CHEMM 0.00 DKK
2013-10-10 Årsstämma 2014
2013-07-25 Extra Bolagsstämma 2013
2013-05-14 Kvartalsrapport 2013-Q3
2012-11-14 Kvartalsrapport 2013-Q1
2012-10-12 Ordinarie utdelning CHEMM 0.00 DKK
2012-10-11 Årsstämma 2013
2012-05-11 Kvartalsrapport 2012-Q3
2011-11-11 Kvartalsrapport 2012-Q1
2011-10-14 Ordinarie utdelning CHEMM 0.00 DKK
2011-10-13 Årsstämma 2012
2011-05-13 Kvartalsrapport 2011-Q3
2010-11-12 Kvartalsrapport 2011-Q1
2010-10-06 Ordinarie utdelning CHEMM 0.00 DKK

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHälsovård
IndustriMedicinteknik
ChemoMetec är verksamma inom medicinteknik. Bolaget är specialiserade inom design, utveckling och produktion av patenterade instrument för cellräkning och cellanalys. Bolaget samarbetar och stadgar avtal med aktörer som forskningsinstitut, universitet, livsmedelsbolag, sjukhus och specialkliniker. Kunderna återfinns på en global marknad. Bolaget grundades ursprungligen under 1997 och har sitt huvudkontor i Alleröd.
Appointment of new CEO
2024-03-13 09:02:09

ANNOUNCEMENT NO. 254


Appointment of new CEO

The Board of Directors of ChemoMetec has decided to appoint the company's current COO Martin Helbo Behrens as new CEO, effective as of today.

The decision is based on the Board’s assessment that ChemoMetec in the current phase of the company's development needs a different composition of executive management skills. Therefore, the board has entered into an agreement with the company's current CEO Rasmus Kofoed to resign from his position as of today.

Martin Helbo Behrens, who is 31 years old, has been employed at ChemoMetec for a number of years. He was originally employed as part of Group Finance, but in 2021 he relocated to the USA to take up a position as first COO and then CFO of ChemoMetec's American subsidiary. In these roles he has made a significant contribution to ChemoMetec's high growth and commercial success in the North American market over recent years. After almost three years in the USA, Martin Helbo Behrens returned to ChemoMetec's head office in Allerød as Deputy COO in 2023 and took up the position as COO on 1 February 2024.

With Martin Helbo Behrens' in-depth insight into ChemoMetec's organization, products and markets, and based on the results he has contributed to creating in ChemoMetec, the Board is convinced that Martin Helbo Behrens will be the right profile to head ChemoMetec as CEO in the future.

CEO Martin Helbo Behrens and CFO Niels Høy Nielsen will hereafter form the executive management of ChemoMetec.


For further information

Chairman of the Board Niels Thestrup, ChemoMetec A/S
Phone: (+45) 3370 2000


About ChemoMetec A/S

ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies, such as Novartis, Novo Nordisk, H. Lundbeck, Merck, AstraZeneca and Johnson & Johnson.

ChemoMetec was founded in 1997 and is listed on the Nasdaq Copenhagen stock exchange. For more information, go to www.chemometec.com


Källa GlobeNewswire Nordic
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden